{"id":"NCT02685709","sponsor":"Chiasma, Inc.","briefTitle":"Comparison of Oral Octreotide Capsules to Injectable Somatostatin Analogs in Acromegaly","officialTitle":"A Phase 3, Randomized, Active Controlled Study to Evaluate Maintenance of Response, Safety and Patient Reported Outcomes in Acromegaly Patients Treated With Octreotide Capsules vs. Parenteral Somatostatin Receptor Ligands","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2016-02","primaryCompletion":"2020-10","completion":"2021-08","firstPosted":"2016-02-19","resultsPosted":"2022-04-22","lastUpdate":"2022-04-22"},"enrollment":146,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Acromegaly"],"interventions":[{"type":"DRUG","name":"Octreotide capsules","otherNames":["Injection SRLs"]}],"arms":[{"label":"Run-in phase","type":"EXPERIMENTAL"},{"label":"RCT phase - Oral","type":"EXPERIMENTAL"},{"label":"RCT phase - Injectables","type":"ACTIVE_COMPARATOR"},{"label":"Combination phase (sub-study)","type":"EXPERIMENTAL"}],"summary":"Octreotide capsule is a novel, orally-administered formulation of the commercially-available injectable drug octreotide. In a recent phase 3 trial (OPTMAL; NCT03252353), oral octreotide capsules demonstrated sustained biochemical response up to 13 months in patients with acromegaly previously managed with somatostatin analog injections (ref).\n\nThe objective of this study was to compare the efficacy, safety, and patient reported outcomes (PROs) between oral octreotide capsules and injectable somatostatin receptor ligands (SRLs).","primaryOutcome":{"measure":"Proportion of Patients Who Are Biochemically Controlled Throughout the RCT Phase","timeFrame":"62 weeks","effectByArm":[{"arm":"RCT Phase - Oral","deltaMin":50,"sd":null},{"arm":"RCT Phase - Injectables","deltaMin":37,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":10},"locations":{"siteCount":53,"countries":["United States","Austria","France","Germany","Hungary","Italy","Lithuania","Poland","Romania","Russia","Serbia","Spain","United Kingdom"]},"refs":{"pmids":["25664604","26610414","34953531"],"seeAlso":["http://www.chiasmapharma.com"]},"adverseEventsSummary":{"seriousAny":{"events":6,"n":146},"commonTop":["Nausea","Flatulence","Diarrhea","Headache","Abdominal pain"]}}